This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shiu, R. P. C. Search for Related Content PubMed PubMed Citation Articles by Shiu, R. P. C.

Prolactin Receptors in Human Breast Cancer Cells in Long-Term Tissue Culture¹

Department of Physiology, University of Manitoba, Faculty of Medicine, Winnipeg, Manitoba, Canada R3E OW3

Prolactin receptors have been identified for the first time in a number of human breast cancer cell lines and a normal human breast cell line maintained in long-term tissue culture. Optimal conditions for determining the binding of ¹²⁵I-labeled human prolactin to these cells were established. Five different tumor cell lines have different content of prolactin receptors ranging from 2,300 to 26,000 sites/cell. All tumor cell lines contained more prolactin receptors than does one normal breast cell line (1700 sites/cell). The prolactin receptors in these human mammary tumor cells not only bind human prolactin but also recognize other lactogenic hormones such as human growth hormone, human placental lactogen, and sheep prolactin, but not animal growth hormone, which are not lactogenic. The affinity (K_a) of binding of human prolactin to these cells is 4 x 10⁹ M^-1 (K_d = 2.5 x 10^-10 M). The hormone specificity and affinity for hormone of these human mammary tumor cells are very similar to that found for the rabbit mammary gland. These human mammary tumor cell lines in long-term culture should prove very useful to study the biology of prolactin receptors in living human cells and the role of prolactin in the tumorigenesis of the human breast.

¹ This investigation was supported Medical Research Council of Canada Grants MA-6248 and ME-6288 and a grant from the J. A. Richardson Foundation, Winnipeg, Manitoba, Canada.

² Scholar of the Medical Research Council of Canada.

Received 9/18/78. Accepted 8/ 2/79.

This article has been cited by other articles:

				L. M. Neilson, J. Zhu, J. Xie, M. G. Malabarba, K. Sakamoto, K.-U. Wagner, R. A. Kirken, and H. Rui Coactivation of Janus Tyrosine Kinase (Jak)1 Positively Modulates Prolactin-Jak2 Signaling in Breast Cancer: Recruitment of ERK and Signal Transducer and Activator of Transcription (Stat)3 and Enhancement of Akt and Stat5a/b Pathways Mol. Endocrinol., September 1, 2007; 21(9): 2218 - 2232. [Abstract] [Full Text] [PDF]

				F. Arturi, E. Ferretti, I. Presta, T. Mattei, A. Scipioni, D. Scarpelli, R. Bruno, L. Lacroix, E. Tosi, A. Gulino, et al. Regulation of Iodide Uptake and Sodium/Iodide Symporter Expression in the MCF-7 Human Breast Cancer Cell Line J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2321 - 2326. [Abstract] [Full Text] [PDF]

				K. C. Leung, N. Doyle, M. Ballesteros, K. Sjogren, C. K. W. Watts, T. H. Low, G. M. Leong, R. J. M. Ross, and K. K. Y. Ho Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2 PNAS, February 4, 2003; 100(3): 1016 - 1021. [Abstract] [Full Text] [PDF]

				C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler The Role of Prolactin in Mammary Carcinoma Endocr. Rev., February 1, 2003; 24(1): 1 - 27. [Abstract] [Full Text] [PDF]

				D. S. Park, H. Lee, C. Riedel, J. Hulit, P. E. Scherer, R. G. Pestell, and M. P. Lisanti Prolactin Negatively Regulates Caveolin-1 Gene Expression in the Mammary Gland during Lactation, via a Ras-dependent Mechanism J. Biol. Chem., December 14, 2001; 276(51): 48389 - 48397. [Abstract] [Full Text] [PDF]

				X. Xu, E. Kreye, C. B. Kuo, and A. M. Walker A Molecular Mimic of Phosphorylated Prolactin Markedly Reduced Tumor Incidence and Size When DU145 Human Prostate Cancer Cells Were Grown in Nude Mice Cancer Res., August 1, 2001; 61(16): 6098 - 6104. [Abstract] [Full Text] [PDF]

				J.-Y. Cho, R. Léveillé, R. Kao, B. Rousset, A. F. Parlow, W. E. Burak Jr., E. L. Mazzaferri, and S. M. Jhiang Hormonal Regulation of Radioiodide Uptake Activity and Na+/I- Symporter Expression in Mammary Glands J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2936 - 2943. [Abstract] [Full Text]

				B. Tsunekawa, M. Wada, M. Ikeda, H. Uchida, N. Naito, and M. Honjo The 20-Kilodalton (kDa) Human Growth Hormone (hGH) Differs from the 22-kDa hGH in the Effect on the Human Prolactin Receptor Endocrinology, September 1, 1999; 140(9): 3909 - 3918. [Abstract] [Full Text]

				P. Touraine, J.-F. Martini, B. Zafrani, J.-C. Durand, F. Labaille, C. Malet, A. Nicolas, C. Trivin, M.-C. Postel-Vinay, F. Kuttenn, et al. Increased Expression of Prolactin Receptor Gene Assessed by Quantitative Polymerase Chain Reaction in Human Breast Tumors Versus Normal Breast Tissues J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 667 - 674. [Abstract] [Full Text]

				G. Fuh and J. A. Wells Prolactin Receptor Antagonists That Inhibit the Growth of Breast Cancer Cell Lines J. Biol. Chem., June 2, 1995; 270(22): 13133 - 13137. [Abstract] [Full Text] [PDF]

				T. J. J. Wood, D. Sliva, P. E. Lobie, T. J. Pircher, F. Gouilleux, H. Wakao, J. Gustafsson, B. Groner, G. Norstedt, and , and Lars-Arne Haldosén Mediation of Growth Hormone-dependent Transcriptional Activation by Mammary Gland Factor/Stat 5 J. Biol. Chem., April 21, 1995; 270(16): 9448 - 9453. [Abstract] [Full Text] [PDF]